These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36185198)

  • 1. Current understanding on the role of CCT3 in cancer research.
    Liu W; Lu Y; Yan X; Lu Q; Sun Y; Wan X; Li Y; Zhao J; Li Y; Jiang G
    Front Oncol; 2022; 12():961733. PubMed ID: 36185198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
    Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
    World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of CCT3 inhibits melanoma cell proliferation by downregulating CDK1 expression.
    Liu W; Zhang X; Chen C; Li Y; Yang C; Han Z; Jiang G; Liu Y
    J Cancer; 2022; 13(6):1958-1971. PubMed ID: 35399722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCT3 suppression prompts apoptotic machinery through oxidative stress and energy deprivation in breast and prostate cancers.
    Temiz E; Koyuncu İ; Sahin E
    Free Radic Biol Med; 2021 Mar; 165():88-99. PubMed ID: 33508424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of
    Shi X; Cheng S; Wang W
    Oncol Lett; 2018 Jun; 15(6):9202-9208. PubMed ID: 29805652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of CCT3 promotes cervical cancer progression through FN1.
    Dou L; Zhang X
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34651664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chaperonin containing TCP1 subunit 3 (CCT3) promotes cisplatin resistance of lung adenocarcinoma cells through targeting the Janus kinase 2/signal transducers and activators of transcription 3 (JAK2/STAT3) pathway.
    Danni X; Jiangzheng Z; Huamao S; Yinglian P; Changcheng Y; Yanda L
    Bioengineered; 2021 Dec; 12(1):7335-7347. PubMed ID: 34612768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer.
    Liu Y; Zhang X; Lin J; Chen Y; Qiao Y; Guo S; Yang Y; Zhu G; Pan Q; Wang J; Sun F
    Cell Death Dis; 2019 Sep; 10(9):644. PubMed ID: 31501420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of chaperonin-containing TCP1 subunit 3 may induce dismal prognosis in multiple myeloma.
    Qian T; Cui L; Liu Y; Cheng Z; Quan L; Zeng T; Huang W; Dai Y; Chen J; Liu L; Chen J; Pang Y; Wu G; Ye X; Shi J; Fu L; Si C
    Pharmacogenomics J; 2020 Aug; 20(4):563-573. PubMed ID: 31902948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCT3 as a Diagnostic and Prognostic Biomarker in Cervical Cancer.
    Li M; Zeng J; Chang Y; Lv L; Ye G
    Crit Rev Eukaryot Gene Expr; 2023; 33(6):17-28. PubMed ID: 37522542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chaperonin containing TCP-1 subunit 3 is critical for gastric cancer growth.
    Li LJ; Zhang LS; Han ZJ; He ZY; Chen H; Li YM
    Oncotarget; 2017 Dec; 8(67):111470-111481. PubMed ID: 29340068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and prognostic value of chaperonin containing T-complex 1 subunit 3 in hepatocellular carcinoma: A Study based on microarray and RNA-sequencing with 4272 cases.
    Hou JY; Wu HY; He RQ; Lin P; Dang YW; Chen G
    Pathol Res Pract; 2019 Jan; 215(1):177-194. PubMed ID: 30473171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of CCT3 inhibits the proliferation and migration in breast cancer cells.
    Xu G; Bu S; Wang X; Zhang H; Ge H
    Cancer Cell Int; 2020; 20():218. PubMed ID: 32518527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and diagnostic value of CCT3 and IQGAP3 in hepatocellular carcinoma.
    Qian EN; Han SY; Ding SZ; Lv X
    Cancer Cell Int; 2016; 16():55. PubMed ID: 27390551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restraint of chaperonin containing T-complex protein-1 subunit 3 has antitumor roles in non-small cell lung cancer via affection of YAP1.
    Shi H; Zhang Y; Wang Y; Fang P; Liu Y; Li W
    Toxicol Appl Pharmacol; 2022 Mar; 439():115926. PubMed ID: 35182550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of CCT3 predicts poor prognosis and promotes cell proliferation via inhibition of ferroptosis and activation of AKT signaling in lung adenocarcinoma.
    Wang K; He J; Tu C; Xu H; Zhang X; Lv Y; Song C
    BMC Mol Cell Biol; 2022 Jun; 23(1):25. PubMed ID: 35773623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of CCT3 as a prognostic factor and correlates with cell survival and invasion of head and neck squamous cell carcinoma.
    Wang Y; Liu P; Zhang Z; Wang J; Cheng Z; Fan C
    Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34505628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular chaperone CCT3 supports proper mitotic progression and cell proliferation in hepatocellular carcinoma cells.
    Zhang Y; Wang Y; Wei Y; Wu J; Zhang P; Shen S; Saiyin H; Wumaier R; Yang X; Wang C; Yu L
    Cancer Lett; 2016 Mar; 372(1):101-9. PubMed ID: 26739059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the roles and driving forces of CCT3 in human tumors.
    Ma J; Song P; Liu X; Ma C; Zheng M; Ren X; Wang R; Liu W; Lu Z; Li J
    Front Pharmacol; 2022; 13():1005855. PubMed ID: 36313331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potential tumor marker: Chaperonin containing TCP‑1 controls the development of malignant tumors (Review).
    Zheng L; Chen X; Zhang L; Qin N; An J; Zhu J; Jin H; Tuo B
    Int J Oncol; 2023 Sep; 63(3):. PubMed ID: 37539774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.